Recent Quotes (30 days)

You have no recent quotes
chg | %

Theratechnologies Inc  

(Public, TSE:TH)   Watch this stock  
Find more results for TH
2.12
+0.01 (0.47%)
Apr 29 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 2.12 - 2.22
52 week 1.06 - 2.72
Open 2.19
Vol / Avg. 217,154.00/243,556.00
Mkt cap 135.89M
P/E 57.14
Div/yield     -
EPS 0.04
Shares 65.62M
Beta 0.92
Inst. own     -
Jul 12, 2016
Q2 2016 Theratechnologies Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Mar 31, 2016
Q1 2016 Theratechnologies Inc Earnings Release
Mar 31, 2016
Q1 2016 Theratechnologies Inc Earnings Call
Feb 24, 2016
Q4 2015 Theratechnologies Inc Earnings Call
Feb 24, 2016
Q4 2015 Theratechnologies Inc Earnings Release
  

Key stats and ratios

Q1 (Feb '16) 2015
Net profit margin -1.75% 5.23%
Operating margin 5.76% 13.79%
EBITD margin - 20.17%
Return on average assets -1.22% 3.80%
Return on average equity -3.05% 11.26%
Employees 17 -
CDP Score - -

Address

2015 Peel St 5th Floor
MONTREAL, QC H3A 1T8
Canada
+1-514-3367800 (Phone)
+1-514-3319691 (Fax)

Website links

Description

Theratechnologies Inc. is a Canada-based specialty pharmaceutical company. The Company addresses medical needs in metabolic disorders to promote healthy ageing among human immunodeficiency virus (HIV) patients. The Company's product, EGRIFTA (tesamorelin for injection), is used for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The Company's EGRIFTA is indicated for the treatment of excess visceral adipose tissue (VAT).

Officers and directors

Dawn Svoronos Independent Chairman of the Board
Age: 61
Luc Tanguay President, Chief Executive Officer, Director
Age: 56
Philippe Dubuc Chief Financial Officer, Senior Vice President
Lyne Fortin Senior Vice President, Chief Commercial Officer
Christian Marsolais Ph.D. Senior Vice President - Scientific Affairs and Alliances
Age: 52
Marie-Noel Colussi Vice President - Finance
Age: 46
Jocelyn Lafond Vice President - Legal Affairs, Corporate Secretary
Age: 47
Pierre Perazzelli Vice President - Pharmaceutical Development
Age: 63
Gilles Cloutier Ph.D. Independent Director
Age: 70
Gerald A Lacoste Independent Director